Delcasertib hydrochloride

盐酸地卡塞替布

Delcasertib hydrochloride

D659093-5mg

5mg

≥98%

避光,干燥,-80℃储存

超低温冰袋运输

Delcasertib (KAI-9803) hydrochloride is a potent and selective δ-protein kinase C ( δPKC ) inhibitor. Delcasertib (KAI-9803) hydrochloride could ameliorate injury associated with ischemia and reperfusion in animal models of acute myocardial infarction (MI Appearance:Solid IC50& Target:δPKC In Vitro:Delcasertib (KAI-9803) is composed of a selective δ-protein kinase C (δPKC) inhibitor peptide derived from the δV1-1 portion of δPKC (termed “cargo peptide”), conjugated reversibly to the cell-penetrating peptide 11-amino acid, arginine-rich sequence of t In Vivo:Delcasertib (KAI-9803, a single intraperitoneal injection) in mice results in the selective inhibition of PKC translocation in the liver, kidney, lung, heart, and brain. Delcasertib (KAI-9803) administration at the end of ischemia has been found to r Biological Activity:Delcasertib (KAI-9803) hydrochloride is a potent and selective δ-protein kinase C ( δPKC ) inhibitor. Delcasertib (KAI-9803) hydrochloride could ameliorate injury associated with ischemia and reperfusion in animal models of acute myocardial infarction (MI

C120H200ClN45O34S2

2916.74 g/mol

H2O : 100 mg/mL (34.28 mM; Need ultrasonic)